Technology Insights

Novartis AG’s patent case: The Judgement of Supreme court of India

The Indian supreme court recently rejected the Novartis patent application for newer form of Glivec/Gleevec (Imatinib Mesylate in beta crystalline form) filed at the Chennai Patent Office based on Section 3 (d) of ‘The Patents Act, 1970. Accordingly, the Glivec case illustrates patent laws and its interpretation can differ from one country to another. Read this article to know more.